Back

Risk stratification of HCM in 2017: the European approach.

20 June 2017 (08:52 - 09:15)
Organised by:
Congress Presentation Part of: Hypertrophic cardiomyopathy genetics and clinical management Molecular biology / genetics EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Professor Perry Mark Elliott

University College London, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Diagnostic and prognostic role of genotyping in HCM.
Professor P. Charron (Paris, FR)
Slides Video
Presentation thumbnail
Atrial fibrillation and outcome in HCM: the American vs. European approach to risk stratification
Professor E. Arbustini (Pavia, IT)
Presentation thumbnail
Ablation in HCM.
Professor L. Di Biase (The Bronx, US)
Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy genetics and clinical management

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

20 June 2017 08:52 CET
You may be interested in
thumbnail
Congress Session
Implications of obstructive hypertrophic cardiomyopathy (oHCM) for heart failure specialists
17 May 2025
thumbnail
Congress Presentation
Sudden cardiac death risk stratification in hypertrophic cardiomyopathy: discrepancies persist among guidelines
27 August 2021
thumbnail
Congress Session
Cardiogenetics in everyday practice
23 June 2023
thumbnail
Congress Presentation
Identification of novel risk profiles for ventricular arrythmias in hypertrophic cardiomyopathy through clustering analysis including left ventricular strain data
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources